NCT07637708

Brief Summary

This clinical trial evaluated a personalized music-embedded sound therapy for adults with chronic subjective tinnitus. Tinnitus is the perception of sound, such as ringing or buzzing, without an external source and can negatively affect quality of life. Participants were randomly assigned to one of two groups. One group received personalized music-embedded desynchronization sound therapy, using tones selected according to each participant's tinnitus frequency and embedded in music. The comparison group received low-frequency sound stimulation embedded in music. Both interventions were designed to be similar for participants. The main objective was to evaluate whether the personalized music-embedded sound therapy reduced tinnitus severity compared with low-frequency sound stimulation. Tinnitus severity was measured using the Tinnitus Handicap Inventory at baseline and during follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 4, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 10, 2026

Completed
Last Updated

June 10, 2026

Status Verified

June 1, 2026

Enrollment Period

1.1 years

First QC Date

June 4, 2026

Last Update Submit

June 4, 2026

Conditions

Keywords

tinnitusMusic therapyDesynchronizationAuditory neuromodulation

Outcome Measures

Primary Outcomes (1)

  • Tinnitus severity

    Tinnitus handicap inventory

    baseline, 1 month, 2 months, 3 months

Study Arms (2)

Music-Integrated Modified Integrated Desynchronization Therapy (mMIDST)

EXPERIMENTAL

Participants allocated to this arm will receive a sound-based neuromodulation therapy consisting of acoustic stimulation sequences embedded within musical tracks. The intervention is designed to deliver patterned auditory stimuli based on the principles of coordinated reset neuromodulation, which aims to reduce abnormal neural synchrony associated with chronic tinnitus. The intervention consists of pre-processed audio files containing therapeutic acoustic stimulation integrated into music tracks. These audio files are delivered through personal listening devices (e.g., smartphone or portable audio player) using standard headphones. Participants will be instructed to listen to the therapeutic audio tracks daily in a quiet environment. The intervention will be self-administered by participants at home.

Other: Music intervention

Low Frequency Stimulation (LFS)

ACTIVE COMPARATOR

Participants in this arm will receive acoustic stimulation consisting of low-frequency tonal sound stimulation delivered through audio tracks. The stimulation is designed as a comparator sound-based intervention for tinnitus. Participants will receive audio files containing low-frequency acoustic stimuli delivered through personal listening devices using standard headphones.

Other: Music intervention

Interventions

Auditory tones music-embedded

Low Frequency Stimulation (LFS)Music-Integrated Modified Integrated Desynchronization Therapy (mMIDST)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 to 75 years.
  • Diagnosis of chronic subjective tinnitus lasting more than 6 months.
  • Non-pulsatile tinnitus.
  • Tonal tinnitus with an identifiable tinnitus frequency.
  • Unilateral or bilateral tinnitus.
  • Ability to understand the study procedures and provide written informed consent.
  • Ability to comply with the assigned sound therapy protocol and follow-up assessments.

You may not qualify if:

  • Pulsatile tinnitus.
  • Non-tonal tinnitus.
  • History of auditory hallucinations.
  • History of Ménière's disease.
  • History of other active middle or inner ear disease with neurological sequelae.
  • Current use of centrally acting medications that could interfere with tinnitus perception or auditory processing.
  • Severe hearing loss preventing adequate perception of the auditory stimuli.
  • Inability to complete the follow-up assessments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínico Universidad de Chile

Santiago, Chile

Location

Related Publications (3)

  • Eggermont JJ, Tass PA. Maladaptive neural synchrony in tinnitus: origin and restoration. Front Neurol. 2015 Feb 17;6:29. doi: 10.3389/fneur.2015.00029. eCollection 2015.

    PMID: 25741316BACKGROUND
  • Adamchic I, Toth T, Hauptmann C, Walger M, Langguth B, Klingmann I, Tass PA. Acute effects and after-effects of acoustic coordinated reset neuromodulation in patients with chronic subjective tinnitus. Neuroimage Clin. 2017 May 28;15:541-558. doi: 10.1016/j.nicl.2017.05.017. eCollection 2017.

    PMID: 28652968BACKGROUND
  • Adamchic I, Hauptmann C, Tass PA. Changes of oscillatory activity in pitch processing network and related tinnitus relief induced by acoustic CR neuromodulation. Front Syst Neurosci. 2012 Apr 5;6:18. doi: 10.3389/fnsys.2012.00018. eCollection 2012.

    PMID: 22493570BACKGROUND

MeSH Terms

Conditions

Tinnitus

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Paul Delano, PhD

    University of Chile

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD; Ph. D candidate in medical sciences program

Study Record Dates

First Submitted

June 4, 2026

First Posted

June 10, 2026

Study Start

October 1, 2024

Primary Completion

November 1, 2025

Study Completion

February 10, 2026

Last Updated

June 10, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because of privacy and confidentiality considerations related to the small sample size. Aggregate results may be reported in scientific publications.

Locations